Metraipolis › archive › dc_5a623cd0dd6a

Unique loop-structured CD19/CD22 bispecific CAR-T-cell therapy for patients with relapsed/refractory diffuse large B-cell lymphoma: an observational study — Europe PMC PMID:41550973

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41550973
DOI
10.1093/abt/tbaf027
License (as archived)
solo-consultazione
Archived
2026-11-08T10:05:26.167Z
SHA-256 of the archived text
df81d48e8cfce65117358b6371db8243eeeb9fa2a139345f657d6e449a57949b
Stable URL of this page
https://metraipolis.com/documento/dc_5a623cd0dd6a

How to cite

Unique loop-structured CD19/CD22 bispecific CAR-T-cell therapy for patients with relapsed/refractory diffuse large B-cell lymphoma: an observational study — Europe PMC PMID:41550973 — Europe PMC (en), https://europepmc.org/article/MED/41550973 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5a623cd0dd6a (Metraipolis archive dc_5a623cd0dd6a, sha256 df81d48e8cfce65117358b6371db8243eeeb9fa2a139345f657d6e449a57949b)
BibTeX
@misc{dc5a623cd0dd6a,
  title = {Unique loop-structured CD19/CD22 bispecific CAR-T-cell therapy for patients with relapsed/refractory diffuse large B-cell lymphoma: an observational study — Europe PMC PMID:41550973},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41550973},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5a623cd0dd6a; sha256 df81d48e8cfce65117358b6371db8243eeeb9fa2a139345f657d6e449a57949b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41550973. Agents can read the archived copy with the MCP tool read_document.